Published online Dec 18, 2021. doi: 10.5500/wjt.v11.i12.503
Peer-review started: July 6, 2021
First decision: July 28, 2021
Revised: August 4, 2021
Accepted: November 14, 2021
Article in press: November 14, 2021
Published online: December 18, 2021
Core Tip: Coronavirus disease 2019 (COVID-19) has not only interrupted the lives of waiting list patients’; it has additionally impacted transplantation policies, transplant surgeries and broken donation chains. Revised guidelines should advise to continue cyclosporine use as an immunosuppressant to the patients during COVID-19 disease excluding some of patients having kidney failure, severe leucopenia or high serum cyclosporine levels.